OpenAI Unveils Rosalind Academic Plan to Offer Free Life Sciences AI to Research Labs
OpenAI is launching the Rosalind Academic Plan, granting eligible U.S. academic labs up to 30 free seats for 12 months to access GPT-Rosalind and the Rosalind workbench.
OpenAI has announced the Rosalind Academic Plan, a new program offering free access to its specialized life sciences model, GPT-Rosalind, alongside the Rosalind workbench for qualifying academic researchers. Under the initiative, eligible university laboratories located in the United States can receive up to 30 Business Standard seats at no charge for up to 12 months. The project aims to assist foundational scientific inquiry by combining frontier reasoning capabilities with domain-specific tool orchestration.
Specialized Capabilities and the Rosalind Workbench
GPT-Rosalind was developed specifically to assist with complex questions across biology, chemistry, and medicine. The model is integrated with the Rosalind workbench, an interface designed to orchestrate specialized scientific tools across medicinal chemistry, genomics, and wet-lab workflows. Early academic adopters are already exploring the system for tasks such as protein engineering and the study of neurodegenerative diseases.
OpenAI notes that the model is built to aid in therapeutic and molecular engineering, including designing candidate drugs, peptides, enzymes, and therapeutic proteins. Researchers can use the system to evaluate and optimize molecular interactions, stability, selectivity, and development viability. The release aligns with OpenAI's broader focus on supporting basic scientific discovery, noting historical milestones where fundamental university work led to transformative breakthroughs such as the Human Genome Project, CRISPR-Cas9 genome editing, and mRNA vaccine development.
Eligibility Criteria and Trusted-Access Governance
The Rosalind Academic Plan is currently open exclusively to academic labs at U.S. universities. Principal investigators (PIs) and laboratory heads are responsible for applying on behalf of their groups and managing user permissions. For institutions without an OpenAI Enterprise agreement, lab leaders apply through a dedicated trusted-access review. Labs at universities that already maintain an Enterprise agreement must apply through their institution's existing enterprise access process.
Due to the sensitive nature of biological and chemical research, OpenAI requires all participants to pass a trusted-access vetting process prior to activation. This evaluation includes verifying the institution's credentials, confirming the identity and professional appointment of the lab lead, and assessing the lab’s ongoing research activities and planned use cases. Each lab must also designate an institutional safety contact. Research data submitted by labs through the Rosalind Academic Plan is not used to train OpenAI models by default, and active monitoring remains in place to ensure compliance while supporting authorized scientific exploration.
What it means for developers
For software engineers and bioinformatics developers, the primary technical consideration is that the Rosalind Academic Plan does not include API access at this time. The 30 seats provide access to GPT-Rosalind and other frontier OpenAI models strictly through the workbench and standard product interfaces rather than programmatic endpoints.
This limitation means developers cannot currently integrate GPT-Rosalind into external data pipelines, automated laboratory execution scripts, or custom web services. Teams building automated bio-computational workflows must continue using general-purpose frontier models or wait for broader API availability. For engineers evaluating foundational model performance across general reasoning tasks, developers can try top AI models cheaply through one API at https://apixoai.online.
Additionally, the plan reveals how AI providers intend to manage specialized, high-capability models in sensitive domains. By requiring institutional identity verification, explicit safety contacts, and use-case reviews before granting access, OpenAI is outlining a governance model that may define how future life sciences and specialized scientific APIs are eventually administered.
Source: Bringing GPT-Rosalind to academic research labs — OpenAI News. Written by the Apixo team from that report.
One key for Claude, GPT, GLM, DeepSeek and more. Pay per token with crypto.
Get your API key
